Literature DB >> 8441904

The incidence of reflux oesophagitis. A study of endoscopy reports from a defined catchment area in Sweden.

L Lööf1, P Götell, B Elfberg.   

Abstract

Very few epidemiologic data on reflux oesophagitis are available. To estimate the incidence of reflux oesophagitis, all reports (n = 6733) of upper gastrointestinal endoscopy performed in patients aged > or = 16 years and living in a defined catchment area of 226,776 inhabitants were examined during a 2-year period. The incidence of reflux oesophagitis was calculated to be 120 per 100,000 inhabitants, and most of the incident cases (88%) were uncomplicated oesophagitis with single or multiple erosions. The incidence of complicated oesophagitis and Barrett's esophagus was 5.6 and 1.7 per 100,000, respectively. The mean age of all incident subjects was 56 +/- 18 years (range, 17-88 years) with a male to female ratio of 2:1. The severity of oesophagitis increased significantly with age (p = 0.0003), and most (75%) of the patients with complicated oesophagitis were > or = 60 years of age. Men had more severe grades of oesophagitis than women (p = 0.0003), and endoscopic evidence of peptic ulcer disease was observed in one of five patients.

Entities:  

Mesh:

Year:  1993        PMID: 8441904     DOI: 10.3109/00365529309096056

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  15 in total

1.  An evidence-based appraisal of reflux disease management--the Genval Workshop Report.

Authors: 
Journal:  Gut       Date:  1999-04       Impact factor: 23.059

Review 2.  Natural history of dyspepsia.

Authors:  Lars Agréus
Journal:  Gut       Date:  2002-05       Impact factor: 23.059

3.  Gastroesophageal reflux in morbidly obese patients treated with gastric banding or vertical banded gastroplasty.

Authors:  K K Ovrebø; J G Hatlebakk; A Viste; H H Bassøe; K Svanes
Journal:  Ann Surg       Date:  1998-07       Impact factor: 12.969

Review 4.  Helicobacter pylori in gastro-oesophageal reflux disease: causal agent, independent or protective factor?

Authors:  J Labenz; P Malfertheiner
Journal:  Gut       Date:  1997-09       Impact factor: 23.059

5.  Effectiveness of acid suppression in preventing gastroesophageal reflux disease (GERD) after successful treatment of Helicobacter pylori infection.

Authors:  T Rokkas; S D Ladas; C Liatsos; E Panagou; A Karameris; S A Raptis
Journal:  Dig Dis Sci       Date:  2001-07       Impact factor: 3.199

6.  Ten years' experience of screening patients with Barrett's oesophagus in a university teaching hospital.

Authors:  C E Macdonald; A C Wicks; R J Playford
Journal:  Gut       Date:  1997-09       Impact factor: 23.059

7.  The cost of long term therapy for gastro-oesophageal reflux disease: a randomised trial comparing omeprazole and open antireflux surgery.

Authors:  H E Myrvold; L Lundell; P Miettinen; S A Pedersen; B Liedman; J Hatlebakk; R Julkunen; K Levander; M Lamm; C Mattson; J Carlsson; N O Ståhlhammar
Journal:  Gut       Date:  2001-10       Impact factor: 23.059

Review 8.  Management of dyspepsia in general practice. A critical assessment.

Authors:  C Tosetti; V Stanghellini
Journal:  Pharmacoeconomics       Date:  1998       Impact factor: 4.981

9.  The significance of cagA(+) Helicobacter pylori in reflux oesophagitis.

Authors:  V J Warburton-Timms; A Charlett; R M Valori; J S Uff; N A Shepherd; H Barr; C A McNulty
Journal:  Gut       Date:  2001-09       Impact factor: 23.059

10.  Compliance with restrictions on the subsidized use of proton pump inhibitors in Australia.

Authors:  P McManus; J Marley; D J Birkett; J Lindner
Journal:  Br J Clin Pharmacol       Date:  1998-10       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.